Enzymatic Wound Debridement Market Size, Share & Trends Analysis Report By Type (Chronic Wounds, Acute Wounds), By Product (Papain Product, Collagenase Product, Others), By End-use (Hospitals, Homecare, Others), By Region, And Segment Forecasts, 2023 - 20

Enzymatic Wound Debridement Market Size, Share & Trends Analysis Report By Type (Chronic Wounds, Acute Wounds), By Product (Papain Product, Collagenase Product, Others), By End-use (Hospitals, Homecare, Others), By Region, And Segment Forecasts, 2023 - 2030


Enzymatic Wound Debridement Market Growth & Trends

The global enzymatic wound debridement market size is expected to reach USD 1,391.8 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a 6.2% CAGR during the forecast period. Introduction of technologically advanced products and rise in incidence of chronic diseases are some of the key factors aiding growth.

Various initiatives are being undertaken by researchers and key players are developing technologically advanced products owing to rising demand for enzymatic wound debridement products globally, which is anticipated to boost market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for treatment of chronic & acute wounds and papain-based products have been predominantly used for treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)—which is derived from pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound debriding drug that can be effectively used in treating deep burn wounds.

The product recently received approval and market players are undertaking initiatives to launch this product under their wound care product portfolio. For instance, in May 2019, Vericel Corporation entered into a supply agreement and exclusive license with MediWound Ltd. with an aim to commercialize the product in North America. The product also received approval in European Union, the U.S., and other international markets. Therefore, such initiatives are anticipated to positively impact growth over the forecast period.

Enzymatic Wound Debridement Market Report Highlights
  • In terms of revenue, acute wounds segment held the largest share in 2022 owing to rising trauma cases
  • Homecare segment is expected to witness fastest growth rate over the forecast period owing to increasing geriatric population suffering from chronic wounds, who prefer homecare over hospital stay
  • Collagenase product segment held the largest share in 2022 due to rising incidence of chronic wounds
  • Asia Pacific is expected to witness fastest growth over the forecast period owing to rising number diabetic patients in this region
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Product outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Industry Outlook
3.1. Market Segmentation
3.2. Market Variable Analysis
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.2.1 Stringent regulatory policies
3.3. Penetration & Growth Prospect Mapping
3.4. Business Environment Analysis tools
3.4.1. SWOT Analysis, by PEST
3.4.2. Porter’s five forces analysis
Chapter 4. Enzymatic Wound Debridement Market: Type Estimates & Trend Analysis
4.1. Enzymatic Wound Debridement Market: Key Takeaways
4.2. Enzymatic Wound Debridement Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. Chronic wounds
4.3.1. Chronic wounds market estimates and forecast 2022 to 2030 (USD Million)
4.3.1.1. Diabetic Foot Ulcers
4.3.1.1.1. Diabetic foot ulcers market estimates and forecast 2022 to 2030 (USD Million)
4.3.1.2. Pressure Ulcers
4.3.1.2.1. Pressure ulcers market estimates and forecast 2022 to 2030 (USD Million)
4.3.1.3. Venous Leg Ulcers
4.3.1.3.1. Venous leg ulcers market estimates and forecast 2022 to 2030 (USD Million)
4.4. Acute Wounds
4.4.1. Acute wounds market estimates and forecast 2022 to 2030 (USD Million)
4.4.1.1. Burns
4.4.1.1.1. Burns market estimates and forecast 2022 to 2030 (USD Million)
4.4.1.2. Other Acute Wounds
4.4.1.2.1. Other acute wounds market estimates and forecast 2022 to 2030 (USD Million)
Chapter 5. Enzymatic Wound Debridement Market: Product Estimates & Trend Analysis
5.1. Enzymatic Wound Debridement Market: Key Takeaways
5.2. Enzymatic Wound Debridement Market: Product Movement & Market Share Analysis, 2022 & 2030
5.3. Collagenase Product
5.3.1. Collagenase Product market estimates and forecasts, 2022 to 2030 (USD Million)
5.4. Papain Product
5.4.1. Papain Product market estimates and forecasts, 2022 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2022 to 2030 (USD Million)
Chapter 6. Enzymatic Wound Debridement Market: End-use Estimates & Trend Analysis
6.1. Enzymatic Wound Debridement Market: Key Takeaways
6.2. Enzymatic Wound Debridement Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Homecare
6.4.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Enzymatic Wound Debridement Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Enzymatic Wound Debridement Market, by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Convatec Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Smith & Nephew
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Mölnlycke Health Care AB
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Integra LifeSciences
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. SOLASCURE Limited
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. B. Braun
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings